Hugh M. Davis
Director, President and COO · 2 filings · Latest: Feb 3, 2026
Aclaris Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ACRS | Hugh M. Davis | Director, President and COO | Feb 3, 2026 | Option Exercise | — | 18,675 | — | 45,425 |